2 Days
Source:
EL PAÍS
Accionistas acusan a Novo Nordisk por nuevo medicamento
The accusation claims that the Danish company deceived investors regarding the doses used in the CagriSema clinical trial.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)